Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07086300
What this trial is testing

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

Who this might be right for
Elderly Patients (>65 Years)Non-Small Cell Lung CancerPD-1 Inhibitors+1 more
Kong Fanming 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07062328
What this trial is testing

A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC

Who this might be right for
Biliary Tract Carcinoma
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Ended earlyNCT04638582
What this trial is testing

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
McGill University Health Centre/Research Institute of the McGill University Health Centre 6
Testing effectiveness (Phase 2)Looking for participantsNCT06255223
What this trial is testing

Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

Who this might be right for
Renal Cell CarcinomaRadiotherapyImmune Checkpoint Inhibitor
Jinling Hospital, China 35
Not applicableLooking for participantsNCT07704918
What this trial is testing

Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

Who this might be right for
Melanoma
University of Colorado, Denver 40
Testing effectiveness (Phase 2)Study completedNCT02601014
What this trial is testing

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

Who this might be right for
Prostate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Early research (Phase 1)Active Not RecruitingNCT04883762
What this trial is testing

Stool Transplant to Control Treatment-related Diarrhea

Who this might be right for
Fecal Microbiota Transplantation (FMT)
Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)UnknownNCT06356701
What this trial is testing

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Who this might be right for
Long-Term Effects Secondary to Cancer Therapy
The First Affiliated Hospital of Dalian Medical University 120
Testing effectiveness (Phase 2)UnknownNCT04414969
What this trial is testing

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Who this might be right for
Immune Checkpoint InhibitorChemotherapy EffectEpigenetic Disorder+1 more
Hunan Cancer Hospital 35
Not applicableStudy completedNCT02651831
What this trial is testing

Development and Validation of a Health-related Quality of Life Instrument

Who this might be right for
Cancer
University Health Network, Toronto 85
Not applicableStudy completedNCT07436390
What this trial is testing

IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma

Who this might be right for
Metastatic MelanomaMalignant MelanomaSkin Cancer
Institute of Oncology Ljubljana 132
Not applicableUnknownNCT05420922
What this trial is testing

Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC

Who this might be right for
Hepatocellular CarcinomaProgrammed Cell Death 1Effects of Immunotherapy
Tongji Hospital 2,000
Not applicableUnknownNCT04507750
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

Who this might be right for
Immune Checkpoint Inhibition
Qianfoshan Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07118566
What this trial is testing

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

Who this might be right for
Gastrointestinal CancerImmunotherapyLiver Metastasis
China Medical University, China 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04407247
What this trial is testing

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Who this might be right for
ColitisLung Non-Small Cell CarcinomaMalignant Genitourinary System Neoplasm+2 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT07284992
What this trial is testing

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC

Who this might be right for
Rectal CancerAdvanced Stage Colorectal CancerRadiotherapy
Shandong Provincial Hospital 208
Testing effectiveness (Phase 2)Looking for participantsNCT05726396
What this trial is testing

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis

Who this might be right for
Immune-related ColitisColitis
University of Minnesota 20
Testing effectiveness (Phase 2)UnknownNCT06413017
What this trial is testing

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Who this might be right for
HCC
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableLooking for participantsNCT07216495
What this trial is testing

Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC

Who this might be right for
Aerobic ExerciseEarly Stage Triple Negative Breast Cancer
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129772
What this trial is testing

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer RecurrentNasopharyngeal Cancinoma (NPC)
The University of Hong Kong 53
Next Page